IRadimed Stock Year Fund Signals Growth and Risk in 2026
A large fund trimmed its IRADIMED stake while the company posted a record quarter, sparking discussion about growth, ...
This guide analyzes beta values across leading coins to identify those with the lowest market sensitivity. Explore interpretation and strategy tips.
26,618 articlesA large fund trimmed its IRADIMED stake while the company posted a record quarter, sparking discussion about growth, ...
A niche investment move places acuta capital erasca (eras) at the center of Erasca's ambitious quest in targeted canc...
A bold move from SpaceX has investors weighing risk and reward. This guide breaks down what the decision could mean f...
Tech leadership returns as Nvidia and Meta strengthen AI bets. This rally lifted major indexes and helped smaller gro...
In a choppy 2026 market, a momentum-focused ETF is gaining attention for its track record of catching leaders while a...
A seasoned financial writer explains how a president-defining stance from the new Fed chair can ripple through stocks...
Cannabis stocks remain volatile and Canopy Growth sits at a crossroads in 2026. This article explains why many invest...
Target delivered a solid beat-and-raise quarter, yet shares slid, illustrating a sell-the-news dynamic. With Walmart ...
Investors are noticing a uptick in service now shares as optimism returns to cloud software. This article breaks down...
A small, overlooked quantum company could ride a wave of lab-to-market commercialization. This guide breaks down why ...
When a prominent fund makes a sizable stake reduction, it often signals more than profit-taking. This article breaks ...
Intel shares slipped about 6% in midday trading as HSBC boosted its price target 60% higher, while AMD and the broade...